BA
LFCR icon

BlackRock Advisors’s Lifecore Biomedical LFCR Stock Holding History

BlackRock Advisors’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$207K Sell
14,972
-502
-3% -$6.96K ﹤0.01% 2702
2016
Q3 		$208K Buy
15,474
+2,912
+23% +$35.3K ﹤0.01% 2671
2016
Q2 		$135K Sell
12,562
-861
-6% -$9.5K ﹤0.01% 2811
2016
Q1 		$141K Buy
13,423
+1,407
+12% +$15.5K ﹤0.01% 2740
2015
Q4 		$142K Sell
12,016
-6,116
-34% -$75.1K ﹤0.01% 2755
2015
Q3 		$212K Sell
18,132
-12,976
-42% -$172K ﹤0.01% 2691
2015
Q2 		$449K Buy
31,108
+469
+2% +$6.77K ﹤0.01% 2265
2015
Q1 		$427K Buy
30,639
+2,398
+8% +$33.1K ﹤0.01% 2187
2014
Q4 		$390K Sell
28,241
-24,269
-46% -$314K ﹤0.01% 2178
2014
Q3 		$643K Buy
52,510
+3,658
+7% +$45.7K ﹤0.01% 1769
2014
Q2 		$610K Sell
48,852
-2,100
-4% -$24.7K ﹤0.01% 1868
2014
Q1 		$569K Buy
50,952
+1,952
+4% +$21.4K ﹤0.01% 1955
2013
Q4 		$594K Buy
49,000
+1,234
+3% +$14.7K ﹤0.01% 1907
2013
Q3 		$583K Buy
47,766
+21,102
+79% +$294K ﹤0.01% 1799
2013
Q2 		$352K Buy
+26,664
New +$369K ﹤0.01% 2088

Other funds holding LFCR

NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Advisors's LFCR Position: Q4 2016 in Review

BlackRock Advisors reduced its Lifecore Biomedical (LFCR) stake by 3.2% in Q4 2016, selling an estimated $6.96K and leaving 14,972 shares worth $207K. The position accounts for ﹤0.01% of the portfolio, ranked #2702.

BlackRock Advisors first reported a position in LFCR in Q2 2013 and has held it in 15 quarters since. The position peaked at $643K in Q3 2014. 93 funds tracked by Wall St. Rank hold LFCR as of Q4 2016.

  • BlackRock Advisors held 14,972 shares of Lifecore Biomedical worth $207K as of Q4 2016.
  • BlackRock Advisors sold 502 Lifecore Biomedical shares in Q4 2016, an estimated $6.96K.
  • Lifecore Biomedical made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2702 holding.
  • BlackRock Advisors first reported a position in Lifecore Biomedical in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Lifecore Biomedical position peaked at $643K in Q3 2014.
  • 93 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.